Australia markets close in 2 hours

Reshape Lifesciences Inc (24O0.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
18.100.00 (0.00%)
At close: 05:36PM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
4,459
3,855
22,765
2,957
-
Total cash
4,459
3,855
22,765
2,957
-
Net receivables
1,659
2,180
2,815
2,620
-
Inventory
3,741
3,611
3,003
2,244
-
Other current assets
139
84
188
159
-
Total current assets
10,296
9,911
29,938
8,944
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
400
1,200
2,060
1,228
-
Accumulated depreciation
-90
-331
-340
-179
-
Net property, plant and equipment
310
869
1,720
1,049
-
Intangible assets
-
260
20,827
27,022
28,674
Other long-term assets
29
46
46
46
-
Total non-current assets
367
1,231
22,593
28,117
-
Total assets
10,663
11,142
52,531
37,061
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
3,609
-
Accounts payable
1,689
1,926
3,468
3,655
-
Accrued liabilities
1,056
3,920
2,308
2,453
-
Deferred revenues
639
510
549
398
-
Other current liabilities
58
491
185
514
-
Total current liabilities
3,777
7,481
7,530
11,605
-
Non-current liabilities
Long-term debt
-
-
-
9,168
-
Deferred tax liabilities
-
0
367
615
702
Total non-current liabilities
223
0
667
10,968
-
Total liabilities
4,000
7,481
8,197
22,573
-
Stockholders' equity
Common stock
23
1
0
5
-
Retained earnings
-635,574
-624,187
-577,973
-514,827
-
Accumulated other comprehensive income
-88
-88
-92
-121
-
Total stockholders' equity
6,663
3,661
44,334
14,488
-
Total liabilities and stockholders' equity
10,663
11,142
52,531
37,061
-